CD207

CD207 molecule, the group of C-type lectin domain containing|CD molecules|Scavenger receptors

Basic information

Region (hg38): 2:70830211-70835816

Links

ENSG00000116031NCBI:50489OMIM:604862HGNC:17935Uniprot:Q9UJ71AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Birbeck granule deficiency (No Known Disease Relationship), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Birbeck granule deficiencyADGeneralThe condition may not involve clinical relevanceGeneralThe clinical relevance of the condition is unclear

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CD207 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD207 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
clinvar
4
clinvar
6
missense
24
clinvar
4
clinvar
5
clinvar
33
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
0
non coding
0
Total 0 0 25 5 10

Variants in CD207

This is a list of pathogenic ClinVar variants found in the CD207 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-70831053-C-T CD207-related disorder Benign (Oct 21, 2019)3060971
2-70831057-T-G not specified Uncertain significance (Dec 09, 2023)3140436
2-70831070-A-G not specified Uncertain significance (May 25, 2022)2290886
2-70831075-C-A not specified Uncertain significance (Aug 17, 2021)2246474
2-70831075-C-T not specified Uncertain significance (Mar 13, 2023)2472617
2-70831095-C-T CD207-related disorder Benign (Oct 18, 2019)3060627
2-70831156-T-G not specified Uncertain significance (Feb 05, 2024)3140434
2-70831177-T-C not specified Uncertain significance (Jan 23, 2024)3140433
2-70831189-G-A not specified Uncertain significance (Oct 14, 2023)3140432
2-70831704-A-G CD207-related disorder Benign (Oct 17, 2019)3059640
2-70831719-T-C not specified Uncertain significance (May 14, 2024)3264772
2-70831728-G-A not specified Uncertain significance (Dec 27, 2023)3140431
2-70831747-A-G Birbeck granule deficiency Uncertain significance (Apr 04, 2024)5337
2-70831794-C-A not specified Uncertain significance (Jun 30, 2023)2609147
2-70831800-G-A not specified Uncertain significance (Aug 16, 2021)2372832
2-70832906-A-G CD207-related disorder Benign (Nov 06, 2019)3059699
2-70832986-G-C not specified Uncertain significance (Dec 26, 2023)3140430
2-70833009-T-G not specified Uncertain significance (May 24, 2024)3264773
2-70833033-A-G not specified Uncertain significance (Nov 28, 2023)3140429
2-70833044-A-C not specified Uncertain significance (May 31, 2023)2569089
2-70833651-C-T not specified Likely benign (Jun 02, 2023)2568886
2-70833685-C-T not specified Likely benign (May 04, 2022)2287533
2-70833699-A-G not specified Uncertain significance (May 10, 2023)2535520
2-70833805-G-C CD207-related disorder Benign (Oct 21, 2019)3060755
2-70833809-G-A Birbeck granule deficiency Uncertain significance (Mar 30, 2021)625908

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CD207protein_codingprotein_codingENST00000410009 65606
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000002820.54165012398921246410.928
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.01711771780.9960.000009732130
Missense in Polyphen4543.3171.0389592
Synonymous-0.2807471.01.040.00000414624
Loss of Function0.7971013.10.7626.43e-7160

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American2.011.90
Ashkenazi Jewish1.000.939
East Asian1.010.933
Finnish1.000.933
European (Non-Finnish)1.000.931
Middle Eastern1.010.933
South Asian1.000.928
Other1.000.921

dbNSFP

Source: dbNSFP

Function
FUNCTION: Calcium-dependent lectin displaying mannose-binding specificity. Induces the formation of Birbeck granules (BGs); is a potent regulator of membrane superimposition and zippering. Binds to sulfated as well as mannosylated glycans, keratan sulfate (KS) and beta-glucans. Facilitates uptake of antigens and is involved in the routing and/or processing of antigen for presentation to T cells. Major receptor on primary Langerhans cells for Candida species, Saccharomyces species, and Malassezia furfur. Protects against human immunodeficiency virus-1 (HIV-1) infection. Binds to high-mannose structures present on the envelope glycoprotein which is followed by subsequent targeting of the virus to the Birbeck granules leading to its rapid degradation. {ECO:0000269|PubMed:10661407, ECO:0000269|PubMed:17334373, ECO:0000269|PubMed:20026605, ECO:0000269|PubMed:20097424}.;
Disease
DISEASE: Birbeck granule deficiency (BIRGD) [MIM:613393]: A condition characterized by the absence of Birbeck granules in epidermal Langerhans cells. Despite the lack of Birbeck granules, Langerhans cells are present in normal numbers and have normal morphologic characteristics and antigen-presenting capacity. {ECO:0000269|PubMed:15816828, ECO:0000269|PubMed:16567809}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Immune System;Adaptive Immune System;Antigen processing-Cross presentation;Class I MHC mediated antigen processing & presentation;Cross-presentation of soluble exogenous antigens (endosomes) (Consensus)

Recessive Scores

pRec
0.160

Haploinsufficiency Scores

pHI
0.0381
hipred
N
hipred_score
0.112
ghis
0.470

Essentials

essential_gene_CRISPR
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.125

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerHighMediumHigh

Mouse Genome Informatics

Gene name
Cd207
Phenotype
immune system phenotype; hematopoietic system phenotype; respiratory system phenotype; liver/biliary system phenotype;

Gene ontology

Biological process
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;receptor-mediated endocytosis;defense response to virus
Cellular component
plasma membrane;integral component of membrane;endocytic vesicle;clathrin-coated endocytic vesicle membrane;early endosome membrane
Molecular function
protein binding;mannose binding;carbohydrate binding